更正：通过六色晶体数字PCR揭示的非小细胞肺癌中的C797S、T790M和致敏突变。
Correction: C797S, T790M and sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR.
作者信息
Madic Jordan, Jovelet Cécile, Lopez Julien, André Barbara, Fatien Jean, Miran Isabelle, Honoré Aurélie, Mezquita Laura, Besse Benjamin, Lacroix Ludovic, Droniou Magali
机构信息
Stilla Technologies, 1 Mail du Professeur Georges Mathé, Villejuif, France.
Plateforme de Génomique, Module de Biopathologie Moléculaire et Centre de Ressources Biologiques, AMMICa, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France.
出版信息
Oncotarget. 2019 Feb 12;10(13):1345. doi: 10.18632/oncotarget.26686.
Abstract
[This corrects the article DOI: 10.18632/oncotarget.26446.].
摘要
[本文更正了文章DOI：10.18632/oncotarget.26446。]
相似文献
1
Correction: C797S, T790M and sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR.更正：通过六色晶体数字PCR揭示的非小细胞肺癌中的C797S、T790M和致敏突变。
Oncotarget. 2019 Feb 12;10(13):1345. doi: 10.18632/oncotarget.26686.
2
C797S, T790M and sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR.六色晶体数字PCR揭示的非小细胞肺癌中的C797S、T790M及敏感突变
Oncotarget. 2018 Dec 21;9(100):37393-37406. doi: 10.18632/oncotarget.26446.
3
Crystal structure of EGFR T790M/C797S/V948R in complex with EAI045.EGFR T790M/C797S/V948R 与 EAI045 复合物的晶体结构
Biochem Biophys Res Commun. 2018 Jul 20;502(3):332-337. doi: 10.1016/j.bbrc.2018.05.154.
4
Most T790M mutations are present on the same EGFR allele as activating mutations in patients with non-small cell lung cancer.在非小细胞肺癌患者中，大多数T790M突变与激活突变位于同一个表皮生长因子受体（EGFR）等位基因上。
Lung Cancer. 2017 Jun;108:75-82. doi: 10.1016/j.lungcan.2017.02.019. Epub 2017 Mar 1.
5
Structural insights into drug development strategy targeting EGFR T790M/C797S.针对表皮生长因子受体（EGFR）T790M/C797S的药物开发策略的结构见解
Oncotarget. 2018 Jan 10;9(17):13652-13665. doi: 10.18632/oncotarget.24113. eCollection 2018 Mar 2.
6
Structural pharmacological studies on EGFR T790M/C797S.表皮生长因子受体（EGFR）T790M/C797S的结构药理学研究
Biochem Biophys Res Commun. 2017 Jun 24;488(2):266-272. doi: 10.1016/j.bbrc.2017.04.138. Epub 2017 Apr 26.
7
Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study).晚期非小细胞肺癌患者对酪氨酸激酶抑制剂获得性耐药血浆中表皮生长因子受体（EGFR）T790M突变的检测（日本西部肿瘤学组8014LTR研究）
Oncotarget. 2016 Sep 6;7(36):58492-58499. doi: 10.18632/oncotarget.11303.
8
EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib.EGFR T790M 和 C797S 突变作为达克替尼获得性耐药的机制。
J Thorac Oncol. 2018 May;13(5):727-731. doi: 10.1016/j.jtho.2018.01.009. Epub 2018 Feb 2.
9
EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.表皮生长因子受体（EGFR）突变与对不可逆嘧啶类EGFR抑制剂的耐药性
Clin Cancer Res. 2015 Sep 1;21(17):3913-23. doi: 10.1158/1078-0432.CCR-14-2789. Epub 2015 May 6.
10
In-silico evidences for binding of Glucokinase activators to EGFR C797S to overcome EGFR resistance obstacle with mutant-selective allosteric inhibition.基于计算机的证据表明，葡萄糖激酶激活剂与 EGFR C797S 结合，通过突变体选择性别构抑制克服 EGFR 耐药障碍。
Comput Biol Chem. 2018 Jun;74:167-189. doi: 10.1016/j.compbiolchem.2018.03.026. Epub 2018 Mar 29.
引用本文的文献
1
Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR.使用晶体数字PCR检测奥希替尼治疗前后非小细胞肺癌患者血浆循环游离DNA和配对循环肿瘤细胞中的表皮生长因子受体（EGFR）突变
Cancers (Basel). 2021 May 31;13(11):2736. doi: 10.3390/cancers13112736.
Zotero 插件